Marc Tessier-Lavigne - Insider Trading & Ownership

Entity
Individual
Location
1 Dna Way, South San Francisco, CA
Summary
The estimated net worth of Marc Tessier-Lavigne is at least $45.5M dollars as of June 4, 2024. Marc Tessier-Lavigne is the Director of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $43.2M. Marc Tessier-Lavigne is the Director of REGENERON PHARMACEUTICALS, INC. and owns shares of REGENERON PHARMACEUTICALS, INC. (REGN) stock worth about $2.32M.
All Insider Reports
All Insider Reports

Ownership of Marc Tessier-Lavigne

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DNLI Denali Therapeutics Inc. Director $43.2M May 31, 2024
REGN REGENERON PHARMACEUTICALS, INC. Director $2.32M Jan 3, 2023

Insider Transactions Reported by Marc Tessier-Lavigne:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.